Assyro AI

Orange Book product · Generic (ANDA)

IFOSFAMIDE

IFOSFAMIDE

Generic (ANDA)ANDA 201689DISCN EXTROVIS

At a glance

Nov 26, 2012

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 26, 2012

    13 yr 9 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

IFOSFAMIDE

Strength

1GM/20ML (50MG/ML)

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

ANDA 201689

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of IFOSFAMIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.